Embryonic stem cells hold much promise – but must be handled with care Description:BSIP SA / Alamy Stock Photo
Embryonic stem cells could help treat all kinds of disorders, and editing the genomes of these stem cells could make the treatments far more potent. But there might be a catch.
A team at Novartis has found that genome editing kills most human embryonic stem cells – and that the ones that do survive are likely to have mutations in a key anti-cancer gene. Cells with such mutations are in theory far more likely to turn cancerous if implanted in the body.…
